Every 10-Q that Leggett & Platt, Inc. (LEG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow LEG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LEG filings page.
Leggett & Platt reported softer first‑quarter 2026 results while agreeing to an all‑stock sale to Somnigroup. Trade sales were $918.2 million, down 10% from a year earlier, and EBIT fell to $44.5 million, pressured by lower volumes and the loss of divested aerospace earnings.
Net earnings declined to $20.0 million, with EPS of $0.14, versus $0.22 last year. Results included a $9.5 million real estate gain, $5.1 million of restructuring and related costs, and $3.5 million of Somnigroup merger expenses. Operating cash flow was negative $56.1 million on working capital build.
In April 2026, Somnigroup agreed to acquire Leggett & Platt in an all‑stock merger; LEG shareholders are expected to receive 0.1455 Somnigroup shares per LEG share and own about 9% of the combined company. The company also disclosed roughly $24 million of Chinese dividend withholding tax assessments, which it plans to contest.
Leggett & Platt (LEG) reported Q3 2025 results showing higher profitability despite softer sales. Net trade sales were $1,036.4M for the quarter (down from $1,101.7M a year ago), while net earnings rose to $127.1M from $44.9M. For the first nine months, sales were $3,116.5M versus $3,327.2M last year, and net earnings improved to $210.2M from a prior loss driven by 2024 goodwill impairments.
Results included an $86.8M gain on the sale of the Aerospace Products Group and additional real estate gains and insurance proceeds. Operating margin improved as cost of goods sold fell, and selling and administrative expenses declined year over year. Cash from operations reached $216.7M year-to-date, supporting debt reduction: long‑term debt decreased to $1,495.8M from $1,862.8M, and cash rose to $460.7M.
The company continued executing its 2024 Restructuring Plan, with life‑to‑date costs of $58.4M toward an expected $75.0M, and amended its credit facility in July 2025, extending maturity to July 24, 2030 with $1,000.0M in revolving commitments. Common stock outstanding was 135,436,282 as of October 28, 2025.